BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25254379)

  • 21. RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation.
    Wang W; Jiang M; Liu S; Zhang S; Liu W; Ma Y; Zhang L; Zhang J; Cao X
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9581-6. PubMed ID: 27506794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ring Finger Protein 34 Facilitates Nervous Necrosis Virus Evasion of Antiviral Innate Immunity by Targeting TBK1 and IRF3 for Ubiquitination and Degradation in Teleost Fish.
    Zhang W; Yao L; Chen L; Jia P; Xiang Y; Yi M; Jia K
    J Virol; 2023 Jun; 97(6):e0053323. PubMed ID: 37255438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6.
    Lin D; Zhang M; Zhang MX; Ren Y; Jin J; Zhao Q; Pan Z; Wu M; Shu HB; Dong C; Zhong B
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11324-9. PubMed ID: 26305951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
    Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3.
    Yu Y; Hayward GS
    Immunity; 2010 Dec; 33(6):863-77. PubMed ID: 21167755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of REC8 in the Innate Immune Response to Viral Infection.
    Chen S; Liu Q; Zhang L; Ma J; Xue B; Li H; Deng R; Guo M; Xu Y; Tian R; Wang J; Cao W; Yang Q; Wang L; Li X; Liu S; Yang D; Zhu H
    J Virol; 2022 Mar; 96(6):e0217521. PubMed ID: 35107381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LYAR Suppresses Beta Interferon Induction by Targeting Phosphorylated Interferon Regulatory Factor 3.
    Yang C; Liu X; Cheng T; Xiao R; Gao Q; Ming F; Jin M; Chen H; Zhou H
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA.
    Zhang M; Zhang MX; Zhang Q; Zhu GF; Yuan L; Zhang DE; Zhu Q; Yao J; Shu HB; Zhong B
    Cell Res; 2016 Dec; 26(12):1302-1319. PubMed ID: 27801882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3.
    Gao P; Ma X; Yuan M; Yi Y; Liu G; Wen M; Jiang W; Ji R; Zhu L; Tang Z; Yu Q; Xu J; Yang R; Xia S; Yang M; Pan J; Yuan H; An H
    Nat Commun; 2021 Feb; 12(1):1194. PubMed ID: 33608556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TANK-binding kinase 1 as a novel therapeutic target for viral diseases.
    Zhao C; Zhao W
    Expert Opin Ther Targets; 2019 May; 23(5):437-446. PubMed ID: 30932713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances and Contradictions in the Study of the Individual Roles of Ubiquitin Ligases That Regulate RIG-I-Like Receptor-Mediated Antiviral Innate Immune Responses.
    Oshiumi H
    Front Immunol; 2020; 11():1296. PubMed ID: 32670286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
    Ran Y; Liu TT; Zhou Q; Li S; Mao AP; Li Y; Liu LJ; Cheng JK; Shu HB
    J Mol Cell Biol; 2011 Oct; 3(5):283-92. PubMed ID: 22028379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WDR5 is essential for assembly of the VISA-associated signaling complex and virus-triggered IRF3 and NF-kappaB activation.
    Wang YY; Liu LJ; Zhong B; Liu TT; Li Y; Yang Y; Ran Y; Li S; Tien P; Shu HB
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):815-20. PubMed ID: 20080758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING.
    Yang LL; Xiao WC; Li H; Hao ZY; Liu GZ; Zhang DH; Wu LM; Wang Z; Zhang YQ; Huang Z; Zhang YZ
    Cell Death Dis; 2022 Oct; 13(10):889. PubMed ID: 36270989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTPN1/2-mediated dephosphorylation of MITA/STING promotes its 20S proteasomal degradation and attenuates innate antiviral response.
    Xia T; Yi XM; Wu X; Shang J; Shu HB
    Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20063-20069. PubMed ID: 31527250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dengue virus targets the adaptor protein MITA to subvert host innate immunity.
    Yu CY; Chang TH; Liang JJ; Chiang RL; Lee YL; Liao CL; Lin YL
    PLoS Pathog; 2012; 8(6):e1002780. PubMed ID: 22761576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF138 Downregulates Antiviral Innate Immunity by Inhibiting IRF3 Activation.
    Zeng X; Liu C; Fan J; Zou J; Guo M; Sun G
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysine 63-linked TANK-binding kinase 1 ubiquitination by mindbomb E3 ubiquitin protein ligase 2 is mediated by the mitochondrial antiviral signaling protein.
    Ye JS; Kim N; Lee KJ; Nam YR; Lee U; Joo CH
    J Virol; 2014 Nov; 88(21):12765-76. PubMed ID: 25142606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNF115 plays dual roles in innate antiviral responses by catalyzing distinct ubiquitination of MAVS and MITA.
    Zhang ZD; Xiong TC; Yao SQ; Wei MC; Chen M; Lin D; Zhong B
    Nat Commun; 2020 Nov; 11(1):5536. PubMed ID: 33139700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication.
    Wang S; Hou P; Pan W; He W; He DC; Wang H; He H
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.